- Home
- AVNT vs PRCT Comparison
AVNT vs PRCT Comparison
Compare AVNT & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVNT
- PRCT
- Stock Information
- Founded
- AVNT 1927
- PRCT 2009
- Country
- AVNT United States
- PRCT United States
- Employees
- AVNT N/A
- PRCT N/A
- Industry
- AVNT Major Chemicals
- PRCT Medical Specialities
- Sector
- AVNT Industrials
- PRCT Health Care
- Exchange
- AVNT Nasdaq
- PRCT Nasdaq
- Market Cap
- AVNT 4.6B
- PRCT 4.3B
- IPO Year
- AVNT 1993
- PRCT 2021
- Fundamental
- Price
- AVNT $51.30
- PRCT $69.08
- Analyst Decision
- AVNT Strong Buy
- PRCT Strong Buy
- Analyst Count
- AVNT 4
- PRCT 6
- Target Price
- AVNT $54.50
- PRCT $78.17
- AVG Volume (30 Days)
- AVNT 422.1K
- PRCT 642.1K
- Earning Date
- AVNT 10-31-2024
- PRCT 10-28-2024
- Dividend Yield
- AVNT 2.11%
- PRCT N/A
- EPS Growth
- AVNT N/A
- PRCT N/A
- EPS
- AVNT 1.27
- PRCT N/A
- Revenue
- AVNT $3,151,400,000.00
- PRCT $176,575,000.00
- Revenue This Year
- AVNT $4.56
- PRCT $62.54
- Revenue Next Year
- AVNT $4.87
- PRCT $40.31
- P/E Ratio
- AVNT $40.40
- PRCT N/A
- Revenue Growth
- AVNT N/A
- PRCT 73.74
- 52 Week Low
- AVNT $27.73
- PRCT $24.83
- 52 Week High
- AVNT $51.51
- PRCT $85.81
- Technical
- Relative Strength Index (RSI)
- AVNT 64.84
- PRCT 37.00
- Support Level
- AVNT $47.85
- PRCT $71.17
- Resistance Level
- AVNT $49.05
- PRCT $74.58
- Average True Range (ATR)
- AVNT 0.85
- PRCT 3.07
- MACD
- AVNT 0.12
- PRCT -0.73
- Stochastic Oscillator
- AVNT 96.10
- PRCT 1.29
About AVNT Avient Corporation
Avient Corp manufactures and sells a variety of chemical and plastic-based products to designers and processors of plastics. The firm operates in two segments: Color, Additives and Inks, and Specialty Engineered Materials. The company's product portfolio includes concentrated color and ink blends, plastic resins, and various specialized polymer materials used in industries such as food packaging, construction, transportation, cosmetics, and healthcare. The color, additives, & ink segment and the distribution segment together generate a vast majority of revenue. More than half of the total revenue is derived from the United States.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System,, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. The company's assets are based in the United States. Its revenue is generated from sales of the AquaBeam Robotic System and the accompanying single-use disposable handpieces.